Glutaredoxin and Pirfenidone  antifibrotic activity in idiopathic pulmonary fibrosis fibroblasts
This study aims to investigate the antifibrotic activity of glutaredoxin in idiopathic pulmonary fibrosis fibroblasts and to determine whether it enhances the therapeutic efficacy of pirfenidone. This work addresses a critical gap in understanding how targeted redox modulation may complement existing antifibrotic therapies and offers translational relevance for improving therapeutic strategies in idiopathic pulmonary fibrosis.